Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

RKIP Downregulation Induces the HBx-Mediated Raf-1 Mitochondrial Translocation

  • Received : 2010.12.20
  • Accepted : 2011.02.22
  • Published : 2011.05.28
Download PDF
⟨ Previous Next ⟩

Abstract

The Raf-1 kinase inhibitory protein (RKIP) can regulate multiple key signaling pathways. Specifically, RKIP binds to Raf-1 kinase and inhibits the Ras-Raf-1-MEK1/2- ERK1/2 pathway. Additionally, Raf-1 has been shown to translocate to mitochondria and thereby protect cells from stress-mediated apoptosis. Recently, HBx was found to stimulate the mitochondrial translocation of Raf-1, contributing to the anti-apoptotic effect. We found that RKIP was downregulated during HBx-mediated hepatocarcinogenesis. In this study, we show that RKIP bound to Raf-1 and consequently inhibited the translocation of Raf-1 into mitochondria. This promoted the apoptosis of cells treated with apoptotic stimulus. Thus, the downregulation of RKIP increased the level of free Raf-1 and thereby elevated the mitochondrial translocation of Raf-1 during HBx-mediated hepatocarcinogenesis. The elevated Raf-1 mitochondrial translocation induced the increased anti-apoptotic effect and subsequently promoted HBx-mediated hepatocarcinogenesis.

Keywords

References

  1. Alexia, C., G. Fallot, M. Lasfer, G. Schweizer-Groyer, and A. Groyer. 2004. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signaling in hepatocarcinogenesis and in the resistance of the hepatocarcinoma cells against drug-induced apoptosis. Biochem. Pharmacol. 68: 1003-1015. https://doi.org/10.1016/j.bcp.2004.05.029
  2. Chen, J. and A. Siddiqui. 2007. Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress. J. Virol. 81: 6757-6760. https://doi.org/10.1128/JVI.00172-07
  3. Corbit, K. C., N. Trakul, E. M. Eves, B. Diaz, M. Marshall, and M. R. Rosner. 2003. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J. Biol. Chem. 278: 13061-13068. https://doi.org/10.1074/jbc.M210015200
  4. Granovsky, A. E. and M. R. Rosner. 2008. Raf kinase inhibitory protein: A signal transduction modulator and metastasis suppressor. Cell Res. 18: 452-457. https://doi.org/10.1038/cr.2008.43
  5. Klysik, J., S. J. Theroux, J. M. Sedivy, J. S. Moffit, and K. Boekelheide. 2008. Signaling crossroads: The function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal. 20: 1-9. https://doi.org/10.1016/j.cellsig.2007.07.003
  6. Lee, H. C., B. Tian, J. M. Sedivy, J. R. Wands, and M. Kim. 2006. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology. 131: 1208-1217. https://doi.org/10.1053/j.gastro.2006.07.012
  7. Lee, T. K., T. C. Lau, and I. O. Ng. 2002. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. Cancer Chemother. Pharmacol. 49: 78-86. https://doi.org/10.1007/s00280-001-0376-4
  8. Lee, Y. I., J. M. Hwang, J. H. Im, Y. I. Lee, N. S. Kim, D. G. Kim, et al. 2004. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J. Biol. Chem. 279: 15460-15471. https://doi.org/10.1074/jbc.M309280200
  9. Kim, S.-Y., P. Y. Lee, H.-J. Shin, D. H. Kim, S. Kang, H.-B. Moon, et al. 2009. Proteomic analysis of liver tissue from HBxtransgenic mice at early stages of hepatocarcinogenesis. Proteomics 9: 5056-5066. https://doi.org/10.1002/pmic.200800779
  10. Neuveut, C., Y. Wei, and M. A. Buendia. 2010. Mechanisms of HBV-related hepatocarcinogenesis. J. Hepatol. 52: 594-604. https://doi.org/10.1016/j.jhep.2009.10.033
  11. Odabaei, G., D. Chatterjee, A. R. Jazirehi, L. Goodglick, K. Yeung, and B. Bonavida. 2004. Raf-1 kinase inhibitor protein: Structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv. Cancer Res. 91: 169-200.
  12. Schuierer, M. M., F. Bataille, T. S. Weiss, C. Hellerbrand, and A. K. Bosserhoff. 2006. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol. Rep. 16: 451-456.
  13. Tang, H., N. Oishi, S. Kaneko, and S. Murakami. 2006. Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci. 97: 977-983. https://doi.org/10.1111/j.1349-7006.2006.00299.x
  14. Xu, Y.-F., Y. Yi, S.-J. Qiu, Q. Gao, Y.-W. Li, C.-X. Dai, et al. 2010. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. J. Hepatol. 53: 872-879. https://doi.org/10.1016/j.jhep.2010.05.019
  15. Jeon, Y.-J., D.-H. Kim, H. Jung, S. J. Chung, S.-W. Chi, S. Cho, et al. 2010. Annexin A4 interacts with the NF-$\kappa$B p50 subunit and modulates NF-$\kappa$B transcriptional activity in a $Ca^{2+}$-dependent manner. Cell Mol. Life Sci. 67: 2271-2281. https://doi.org/10.1007/s00018-010-0331-9

Cited by

  1. Low RKIP expression associates with poor prognosis in bladder cancer patients vol.462, pp.4, 2011, https://doi.org/10.1007/s00428-013-1388-2
  2. Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression vol.22, pp.6, 2011, https://doi.org/10.3390/ijms22063052